| Literature DB >> 20816094 |
Jessica Nouws1, Leo Nijtmans, Sander M Houten, Mariël van den Brand, Martijn Huynen, Hanka Venselaar, Saskia Hoefs, Jolein Gloerich, Jonathan Kronick, Timothy Hutchin, Peter Willems, Richard Rodenburg, Ronald Wanders, Lambert van den Heuvel, Jan Smeitink, Rutger O Vogel.
Abstract
Acyl-CoA dehydrogenase 9 (ACAD9) is a recently identified member of the acyl-CoA dehydrogenase family. It closely resembles very long-chain acyl-CoA dehydrogenase (VLCAD), involved in mitochondrial beta oxidation of long-chain fatty acids. Contrary to its previously proposed involvement in fatty acid oxidation, we describe a role for ACAD9 in oxidative phosphorylation. ACAD9 binds complex I assembly factors NDUFAF1 and Ecsit and is specifically required for the assembly of complex I. Furthermore, ACAD9 mutations result in complex I deficiency and not in disturbed long-chain fatty acid oxidation. This strongly contrasts with its evolutionary ancestor VLCAD, which we show is not required for complex I assembly and clearly plays a role in fatty acid oxidation. Our results demonstrate that two closely related metabolic enzymes have diverged at the root of the vertebrate lineage to function in two separate mitochondrial metabolic pathways and have clinical implications for the diagnosis of complex I deficiency. 2010 Elsevier Inc. All rights reserved.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20816094 DOI: 10.1016/j.cmet.2010.08.002
Source DB: PubMed Journal: Cell Metab ISSN: 1550-4131 Impact factor: 27.287